Yukari Shirasugi

Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment

Masaya Okada, Jun Imagawa, Hideo Tanaka et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 117 citations · Full text

Medicine, Oncology, Pharmacology +9

Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients: a double-blind, randomized Phase III clinical trial

Yukari Shirasugi, Kiyoshi Ando, Kôji Miyazaki et al. · International Journal of Hematology · 2011 · 108 citations

Medicine, Hematology, Pharmacology +10

Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: Relationship with type of latent Epstein‐Barr virus infection

Takuya Miyazaki, Katsumichi Fujimaki, Yukari Shirasugi et al. · American Journal of Hematology · 2007 · 98 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

Multicenter phase <scp>II</scp> study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma

Dai Maruyama, Kiyohiko Hatake, Tomohiro Kinoshita et al. · Cancer Science · 2017 · 53 citations · Full text

Medicine, Immunology, Oncology +17

Phase I study of tirabrutinib (<scp>ONO</scp>‐4059/<scp>GS</scp>‐4059) in patients with relapsed or refractory B‐cell malignancies in Japan

Wataru Munakata, Kiyoshi Ando, Kiyohiko Hatake et al. · Cancer Science · 2019 · 51 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17